NCT05308056

Brief Summary

Aim: To describe anesthetic depth using spectal edge frequency (SEF) and density spectral array (DSA) and its relation to treatment effect of electroconvulsive therapy (ECT). Study design: Observational study Primary outcomes: SEF, DSA and treatment effect of ECT. Method: SEF and DSA si measured using a commercially available monitor for depth of anesthesia. Treatment effect of ECT will be evaluated using hemodynamic, electroencephalographic and clinical variables.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
37

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 23, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 1, 2022

Completed
18 days until next milestone

Study Start

First participant enrolled

April 19, 2022

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 6, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 6, 2023

Completed
Last Updated

March 30, 2023

Status Verified

February 1, 2022

Enrollment Period

10 months

First QC Date

February 23, 2022

Last Update Submit

March 29, 2023

Conditions

Keywords

General anesthesiaElectroencephalogramAwarenessDepth of anesthesiaDepression

Outcome Measures

Primary Outcomes (6)

  • Change in spectral edge frequency

    The spectral edge frequency of the patients electroencephalogram

    Monitored before, during and after ECT. Total monitoring time is apporximately 30 minutes per patient.

  • Change in density spectral array

    The density spectral array of the patients electroencephalogram

    Monitored before, during and after ECT. Total monitoring time is approximately 30 minutes per patient.

  • Duration of convulsive activity

    Measures the duration of both motor and encephalographic convulsions directly following ECT.

    Monitored immediately after administration of ECT.

  • Postictal supression

    Measures the degree of encephalographic supression directly following ECT

    Monitored immediately after administration of ECT.

  • Need for restimulation

    Measures if there is a need for restimulation directly after evaluating the effect of an administered ECT.

    Monitored immediately after administration of ECT.

  • Change in heart rate.

    Mesaures the increase in heart rate directly following ECT.

    Monitored immediately after administration of ECT.

Secondary Outcomes (10)

  • Awareness

    Patients are asked at a follow up visit approximately 1 week after a course of several ECT:s.

  • Adverse effects of ECT

    Patients are asked at a follow up visit approximately 1 week after a course of several ECT:s.

  • Desaturation

    Monitored immediately before pre-oxygenation, during the entire ECT and until the patient has recovered. Approximately 1 hours of total monitoring time.

  • End-tidal CO2

    During induction of general anesthesia

  • Change in depressive symtoms

    Patients are asked at a follow up visit approximately 1 week after a course of several ECT:s and before ECT.

  • +5 more secondary outcomes

Study Arms (1)

ECT-patients

Patients receiving routine ECT.

Device: Depth of anesthesia monitor, SedLine® (Masimo, Irvine, CA, USA)

Interventions

The device monitors the patient's electroencephalogram using electrodes applied to the forehead.

ECT-patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All patients admitted for ECT during the study period

You may qualify if:

  • Admitted for a course of ECT

You may not qualify if:

  • Not able to attach electrodes for measurement of depth of anesthesia due to eg. skin condition.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universitetssjukhuset Örebro

Örebro, Bok 1613, 70116, Sweden

Location

Related Publications (8)

  • UK ECT Review Group. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet. 2003 Mar 8;361(9360):799-808. doi: 10.1016/S0140-6736(03)12705-5.

    PMID: 12642045BACKGROUND
  • Minelli A, Abate M, Zampieri E, Gainelli G, Trabucchi L, Segala M, Sartori R, Gennarelli M, Conca A, Bortolomasi M. Seizure Adequacy Markers and the Prediction of Electroconvulsive Therapy Response. J ECT. 2016 Jun;32(2):88-92. doi: 10.1097/YCT.0000000000000274.

    PMID: 26397151BACKGROUND
  • Zolezzi M. Medication management during electroconvulsant therapy. Neuropsychiatr Dis Treat. 2016 Apr 19;12:931-9. doi: 10.2147/NDT.S100908. eCollection 2016.

    PMID: 27143894BACKGROUND
  • Kronsell A, Nordenskjold A, Bell M, Amin R, Mittendorfer-Rutz E, Tiger M. The effect of anaesthetic dose on response and remission in electroconvulsive therapy for major depressive disorder: nationwide register-based cohort study. BJPsych Open. 2021 Mar 23;7(2):e71. doi: 10.1192/bjo.2021.31.

    PMID: 33752777BACKGROUND
  • Guerrier G, Gianni MA. The effectiveness of BIS monitoring during electro-convulsive therapy: A systematic review and meta-analysis. J Clin Anesth. 2019 Dec;58:100-104. doi: 10.1016/j.jclinane.2019.05.006. Epub 2019 May 28.

    PMID: 31151038BACKGROUND
  • Li X, Cheng N, Deng Y, Du J, Zhang M, Guo Y, Hei Z. Incidence and risk factors for postictal delirium in patients after electroconvulsive therapy in China. Asian J Psychiatr. 2020 Oct;53:102361. doi: 10.1016/j.ajp.2020.102361. Epub 2020 Aug 25. No abstract available.

    PMID: 32890981BACKGROUND
  • Tsujii T, Uchida T, Suzuki T, Mimura M, Hirano J, Uchida H. Factors Associated With Delirium Following Electroconvulsive Therapy: A Systematic Review. J ECT. 2019 Dec;35(4):279-287. doi: 10.1097/YCT.0000000000000606.

    PMID: 31764452BACKGROUND
  • Eertmans W, De Deyne C, Genbrugge C, Marcus B, Bouneb S, Beran M, Fret T, Gutermann H, Boer W, Vander Laenen M, Heylen R, Mesotten D, Vanelderen P, Jans F. Association between postoperative delirium and postoperative cerebral oxygen desaturation in older patients after cardiac surgery. Br J Anaesth. 2020 Feb;124(2):146-153. doi: 10.1016/j.bja.2019.09.042. Epub 2019 Dec 18.

    PMID: 31862160BACKGROUND

MeSH Terms

Conditions

Mood DisordersPsychotic DisordersDepression

Condition Hierarchy (Ancestors)

Mental DisordersSchizophrenia Spectrum and Other Psychotic DisordersBehavioral SymptomsBehavior

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 23, 2022

First Posted

April 1, 2022

Study Start

April 19, 2022

Primary Completion

February 6, 2023

Study Completion

February 6, 2023

Last Updated

March 30, 2023

Record last verified: 2022-02

Locations